ARTL (Artelo Biosciences) Dividends Received


ARTL Artelo Biosciences Inc ARTL
31 GF Score
Price $1.08
! 2 Warning Signs
View Full Analysis

What is Artelo Biosciences Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

ARTL
31GF Score
Artelo Biosciences Inc ARTL
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artelo Biosciences Business Description

Address 505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
31GF Score

Get the complete analysis for ARTL

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.08
Price